Pre–B cell colony‐enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix‐degrading activities
Open Access
- 30 August 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (9), 2829-2839
- https://doi.org/10.1002/art.22833
Abstract
Objective To study possible mechanisms that mediate induction of the recently described adipocytokine pre–B cell colony‐enhancing factor (PBEF) in joints of patients with rheumatoid arthritis (RA), and to analyze whether levels of PBEF correlate with disease severity and whether PBEF itself has the potential to act as a proinflammatory and destructive mediator in RA. Methods RA synovial fibroblasts (RASFs) and monocytes were stimulated with Toll‐like receptor (TLR) ligands, cytokines, and recombinant human PBEF or were transfected with PBEF expression constructs or with PBEF‐specific small interfering RNA. Production of interleukin‐6 (IL‐6), IL‐8, and tumor necrosis factor α (TNFα) was measured by enzyme‐linked immunosorbent assay, and expression of matrix metalloproteinases (MMPs) was assessed by real‐time polymerase chain reaction. PBEF expression in synovial tissue, synovial fluid, serum, and SFs was assessed by immunohistochemistry, in situ hybridization, Western blotting, and enzyme immunoassays. Results In RASFs, PBEF was up‐regulated by TLR ligands and cytokines that are characteristically present in the joints of patients with RA. In synovial tissue, RASFs were the major PBEF‐expressing cells. A predominance of PBEF was found in the synovial lining layer and at sites of invasion into cartilage. Levels of PBEF in serum and synovial fluid correlated with the degree of inflammation and clinical disease activity. Moreover, PBEF itself activated the transcription factors NF‐kB and activator protein 1 and induced IL‐6, IL‐8, MMP‐1, and MMP‐3 in RASFs as well as IL‐6 and TNFα in monocytes. PBEF knockdown in RASFs significantly inhibited basal and TLR ligand–induced production of IL‐6, IL‐8, MMP‐1, and MMP‐3. Conclusion Our findings establish PBEF as a proinflammatory and destructive mediator of joint inflammation in RA and identify PBEF as a potential therapeutic target.Keywords
This publication has 31 references indexed in Scilit:
- RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll‐like receptor 3Arthritis & Rheumatism, 2005
- Pre–B-Cell Colony–Enhancing Factor Regulates NAD + -Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell MaturationCirculation Research, 2005
- The role of Toll-like receptor signalling in the pathogenesis of arthritisCellular Immunology, 2005
- Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of InsulinScience, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Pre–B cell colony–enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsisJCI Insight, 2004
- Chemokine Secretion of Rheumatoid Arthritis Synovial Fibroblasts Stimulated by Toll-Like Receptor 2 LigandsPublished by The American Association of Immunologists ,2004
- Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll‐like receptor signalingArthritis & Rheumatism, 2003
- Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesisEuropean Journal of Immunology, 2002
- Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.Molecular and Cellular Biology, 1994